Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BAY3546828 |
Trade Name | |
Synonyms | BAY 3546828|actinium-225-macropa-pelgifatamab|225Ac-pelgi|225Ac-pelgifatamab |
Drug Descriptions |
BAY3546828 comprises a monoclonal antibody that targets PSMA linked to the radionuclide Actinium-225, which potentially inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 5047). |
DrugClasses | PSMA Antibody 20 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BAY3546828 | BAY3546828 | 0 | 1 |
BAY3546828 + Darolutamide | BAY3546828 Darolutamide | 0 | 0 |